Compile Data Set for Download or QSAR
Report error Found 380 Enz. Inhib. hit(s) with all data for entry = 11367
TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Affinity DataIC50: 2nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165350(US9062043, Table 20b, Compound 11 | US9062043, Tab...)
Affinity DataIC50: 3nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165360(US9062043, Table 20b, Compound 19 | US9062043, Tab...)
Affinity DataIC50: 3nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 4nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165341(US9062043, Table 20b, Compound 5 | US9062043, Tabl...)
Affinity DataIC50: 4nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165367(US9062043, Table 13, Compound 34 | US8168651, Comp...)
Affinity DataIC50: 4nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165394(US9062043, Table 13, Compound 62 | US8168651, Comp...)
Affinity DataIC50: 4nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165363(US9062043, Table 20b, Compound 21 | US9062043, Tab...)
Affinity DataIC50: 5nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165366(US9062043, Table 20b, Compound 24 | US9062043, Tab...)
Affinity DataIC50: 5nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165207(US9062043, Table 13, Compound 1 | US9062043, Table...)
Affinity DataIC50: 6nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165341(US9062043, Table 20b, Compound 5 | US9062043, Tabl...)
Affinity DataIC50: 6nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165352(US9062043, Table 20b, Compound 13 | US9062043, Tab...)
Affinity DataIC50: 6nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165353(US9062043, Table 20b, Compound 14 | US9062043, Tab...)
Affinity DataIC50: 6nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165355(US9062043, Table 20b, Compound 15 | US9062043, Tab...)
Affinity DataIC50: 6nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165416(US9062043, Table 13, Compound 84 | US8168651, Comp...)
Affinity DataIC50: 6nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165420(US9062043, Table 13, Compound 88 | US8168651, Comp...)
Affinity DataIC50: 6nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 7nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165354(US9062043, Table 13, Compound 21 | US8168651, Comp...)
Affinity DataIC50: 7nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165359(US9062043, Table 20b, Compound 18 | US9062043, Tab...)
Affinity DataIC50: 7nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165364(US9062043, Table 20b, Compound 22 | US9062043, Tab...)
Affinity DataIC50: 7nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165399(US9062043, Table 20b, Compound 31 | US9062043, Tab...)
Affinity DataIC50: 7nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165362(US9062043, Table 13, Compound 29 | US8168651, Comp...)
Affinity DataIC50: 9nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165387(US9062043, Table 13, Compound 55 | US8168651, Comp...)
Affinity DataIC50: 9nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165396(US9062043, Table 20b, Compound 29 | US9062043, Tab...)
Affinity DataIC50: 9nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165207(US9062043, Table 13, Compound 1 | US9062043, Table...)
Affinity DataIC50: 10nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165451(US9062043, Table 13, Compound 119 | US8168651, Com...)
Affinity DataIC50: 10nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165390(US9062043, Table 20b, Compound 27 | US9062043, Tab...)
Affinity DataIC50: 11nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165421(US9062043, Table 13, Compound 89 | US8168651, Comp...)
Affinity DataIC50: 11nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165207(US9062043, Table 13, Compound 1 | US9062043, Table...)
Affinity DataIC50: 13nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165389(US9062043, Table 20b, Compound 26 | US9062043, Tab...)
Affinity DataIC50: 13nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165445(US9062043, Table 13, Compound 113 | US8168651, Com...)
Affinity DataIC50: 14nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165449(US9062043, Table 13, Compound 117 | US8168651, Com...)
Affinity DataIC50: 14nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165444(US9062043, Table 13, Compound 112 | US8168651, Com...)
Affinity DataIC50: 15nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165365(US9062043, Table 20b, Compound 23 | US9062043, Tab...)
Affinity DataIC50: 16nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165439(US9062043, Table 13, Compound 107 | US8168651, Com...)
Affinity DataIC50: 16nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165358(US9062043, Table 13, Compound 40 | US9062043, Tabl...)
Affinity DataIC50: 18nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165388(US9062043, Table 13, Compound 56 | US8168651, Comp...)
Affinity DataIC50: 18nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165392(US9062043, Table 13, Compound 60 | US8168651, Comp...)
Affinity DataIC50: 18nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165425(US9062043, Table 13, Compound 93 | US8168651, Comp...)
Affinity DataIC50: 18nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165336(US9062043, Table 20b, Compound 2 | US9062043, Tabl...)
Affinity DataIC50: 19nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165358(US9062043, Table 13, Compound 40 | US9062043, Tabl...)
Affinity DataIC50: 19nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetPoly [ADP-ribose] polymerase 1(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM610121(US8168651, Compound TABLE 15.43)
Affinity DataIC50: 20nMAssay Description:PARP assays are conducted using a chemiluminescent PARP assay kit (Trevigen). Briefly, reactions are performed in Histone-coated strip wells, by addi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165376(US9062043, Table 13, Compound 44 | US8168651, Comp...)
Affinity DataIC50: 20nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165398(US9062043, Table 13, Compound 66 | US8168651, Comp...)
Affinity DataIC50: 20nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165454(US9062043, Table 13, Compound 122 | US8168651, Com...)
Affinity DataIC50: 20nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165413(US9062043, Table 13, Compound 81 | US8168651, Comp...)
Affinity DataIC50: 21nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165443(US9062043, Table 13, Compound 111 | US8168651, Com...)
Affinity DataIC50: 23nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165336(US9062043, Table 20b, Compound 2 | US9062043, Tabl...)
Affinity DataIC50: 25nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165377(US9062043, Table 13, Compound 45 | US8168651, Comp...)
Affinity DataIC50: 26nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165418(US9062043, Table 13, Compound 86 | US8168651, Comp...)
Affinity DataIC50: 26nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 380 total ) | Next | Last >>
Jump to: